Oxycodone Drugs Global Market Report 2025

Description

Oxycodone drug is a powerful opioid analgesic prescribed mainly to alleviate moderate to severe pain. Classified as an opioid agonist, it operates on precise receptors in the brain and spinal cord, modifying the perception of pain. When used properly and under medical supervision, oxycodone serves as an efficient method for pain management.

The primary classifications of oxycodone drugs encompass short-acting and long-acting formulations. Short-acting variants offer prompt pain relief with a brief duration of effect, typically employed for addressing acute pain instances such as post-surgery discomfort or injury-related pain. Oxycodone drugs are available in tablet, capsule, and injectable forms, prescribed for indications such as neuropathic pain, musculoskeletal pain, cancer-related pain, postoperative discomfort, among others. Their distribution spans across hospital pharmacies, retail outlets, and online platforms.

The oxycodone drugs market research report is one of a series of new reports from The Business Research Company that provides oxycodone drugs market statistics, including oxycodone drugs industry global market size, regional shares, competitors with a oxycodone drugs market share, detailed oxycodone drugs market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone drugs industry. This oxycodone drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oxycodone drugs market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $6.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to an aggressive marketing campaign for oxycontin, the drug was marketed for chronic non-malignant pain and cancer, the number of oxycontin prescriptions for non-cancer-related pain increased the demand for these drugs and after the second world war, synthetic opiates like oxycodone began to enter the market in greater numbers.

The oxycodone drugs market size is expected to see strong growth in the next few years. It will grow to $7.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the increasing prevalence of chronic pain, rising number of surgical procedures, ongoing development in the products pipeline is expected to boost the growth, advancements in drug delivery systems and a rising aging population worldwide experiencing a higher incidence of chronic pain. Major trends in the forecast period include increased demand for abuse-deterrent formulations (ADFS), the development of novel delivery systems, the growing use of combination therapies, and technological advancements in manufacturing.

The considerable prevalence of orthopedic disorders is poised to drive the expansion of the oxycodone drug market in the foreseeable future. Orthopedic disorders encompass various musculoskeletal conditions affecting bones, joints, ligaments, tendons, and muscles, often resulting in pain, restricted mobility, and functional impairments. The escalating occurrence of orthopedic disorders can be attributed to factors such as aging demographics, sedentary lifestyles, obesity, sports-related injuries, and occupational risks. Oxycodone drugs play a crucial role in managing orthopedic disorders by alleviating both acute and chronic pain associated with conditions such as fractures, joint injuries, or post-surgical recovery, offering effective relief through modulation of pain receptors in the central nervous system. For example, data from the Institute for Health Metrics and Evaluation, a US-based research institute, projects a substantial increase of approximately 115% (with a range of 107-124%) in musculoskeletal disorder cases (orthopedic disorders) from 2020 to 2050, reaching an estimated 1,060 million prevalent cases by 2050. Hence, the substantial burden of orthopedic disorders underpins the growth trajectory of the oxycodone drug market.

Major companies in the oxycodone drug market are concentrating their efforts on developing innovative medications, such as oxycodone immediate-release (IR) tablets, to mitigate drug abuse via injection and intranasal administration. Oxycodone immediate-release (IR) tablets are a formulation of the opioid analgesic oxycodone intended to deliver swift pain relief. For example, in July 2022, Protega Pharmaceuticals LLC, a US-based pharmaceutical firm, introduced RoxyBond (oxycodone) immediate-release (IR) tablets in the United States. RoxyBond has obtained approval from the U.S. Food and Drug Administration (FDA) as an opioid agonist for severe pain management when other treatment options are insufficient. RoxyBond is equipped with advanced technology to deter misuse and abuse, making it challenging to tamper with physically or chemically. Studies have shown that RoxyBond demonstrates reduced potential for abuse compared to traditional oxycodone tablets, as evidenced by lower ratings for drug liking and desire for repeat consumption.

In February 2023, UNC Kenan-Flagler Business School, a US-based institution specializing in the Business of Health (CBOH), collaborated with Acadia Healthcare to create a flexible opioid settlement playbook. This collaboration seeks to outline the most efficient strategies for communities to deploy opioid settlement funds, particularly as communities nationwide, including those in North Carolina, are receiving substantial allocations to bolster opioid recovery initiatives from legal settlements involving opioid manufacturers and pharmacy chains. Acadia Healthcare Company, Inc. is a US-based organization offering behavioral healthcare services.

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oxycodone drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oxycodone drugs market consists of sales of hydrocodone, morphine, codeine, fentanyl, and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxycodone Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oxycodone drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oxycodone drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxycodone drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Short Acting Oxycodone; Long Acting Oxycodone
2) By Dosage Form: Tablets; Capsules; Injections
3) By Indication: Neuropathic Pain; Musculoskeletal Pain; Cancer Pain; Post Operative Pain; Other Indications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets; Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets; Oxycodone Controlled-Release Formulations
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd; Daiichi Sankyo Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30868

1. Executive Summary

2. Oxycodone Drugs Market Characteristics

3. Oxycodone Drugs Market Trends And Strategies

4. Oxycodone Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oxycodone Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Oxycodone Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Oxycodone Drugs Market Growth Rate Analysis
5.4. Global Oxycodone Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Oxycodone Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Oxycodone Drugs Total Addressable Market (TAM)

6. Oxycodone Drugs Market Segmentation

6.1. Global Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short Acting Oxycodone
Long Acting Oxycodone
6.2. Global Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Injections
6.3. Global Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neuropathic Pain
Musculoskeletal Pain
Cancer Pain
Post Operative Pain
Other Indications
6.4. Global Oxycodone Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Oxycodone Drugs Market, Sub-Segmentation Of Short Acting Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Oxycodone Tablets
Oxycodone Oral Solution
6.6. Global Oxycodone Drugs Market, Sub-Segmentation Of Long Acting Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Extended-Release Oxycodone Tablets
Oxycodone Controlled-Release Formulations

7. Oxycodone Drugs Market Regional And Country Analysis

7.1. Global Oxycodone Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Oxycodone Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oxycodone Drugs Market

8.1. Asia-Pacific Oxycodone Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oxycodone Drugs Market

9.1. China Oxycodone Drugs Market Overview
9.2. China Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oxycodone Drugs Market

10.1. India Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oxycodone Drugs Market

11.1. Japan Oxycodone Drugs Market Overview
11.2. Japan Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oxycodone Drugs Market

12.1. Australia Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oxycodone Drugs Market

13.1. Indonesia Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oxycodone Drugs Market

14.1. South Korea Oxycodone Drugs Market Overview
14.2. South Korea Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oxycodone Drugs Market

15.1. Western Europe Oxycodone Drugs Market Overview
15.2. Western Europe Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oxycodone Drugs Market

16.1. UK Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oxycodone Drugs Market

17.1. Germany Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oxycodone Drugs Market

18.1. France Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oxycodone Drugs Market

19.1. Italy Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oxycodone Drugs Market

20.1. Spain Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oxycodone Drugs Market

21.1. Eastern Europe Oxycodone Drugs Market Overview
21.2. Eastern Europe Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oxycodone Drugs Market

22.1. Russia Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oxycodone Drugs Market

23.1. North America Oxycodone Drugs Market Overview
23.2. North America Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oxycodone Drugs Market

24.1. USA Oxycodone Drugs Market Overview
24.2. USA Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oxycodone Drugs Market

25.1. Canada Oxycodone Drugs Market Overview
25.2. Canada Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oxycodone Drugs Market

26.1. South America Oxycodone Drugs Market Overview
26.2. South America Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oxycodone Drugs Market

27.1. Brazil Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oxycodone Drugs Market

28.1. Middle East Oxycodone Drugs Market Overview
28.2. Middle East Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oxycodone Drugs Market

29.1. Africa Oxycodone Drugs Market Overview
29.2. Africa Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oxycodone Drugs Market Competitive Landscape And Company Profiles

30.1. Oxycodone Drugs Market Competitive Landscape
30.2. Oxycodone Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Oxycodone Drugs Market Other Major And Innovative Companies

31.1. Sun Pharmaceutical Industries Ltd
31.2. Purdue Pharma L.P
31.3. Endo International plc
31.4. Amneal Pharmaceuticals LLC
31.5. Mundipharma Pty Limited
31.6. Alkermes plc
31.7. Mallinckrodt Pharmaceuticals
31.8. Alvogen Group Inc.
31.9. Collegium Pharmaceutical Inc.
31.10. Lannett Company Inc.
31.11. Acorda Therapeutics Inc.
31.12. Camurus AB
31.13. Rhodes Pharmaceuticals L.P.
31.14. KVK Tech Inc.
31.15. Teikoku Pharma USA Inc.

32. Global Oxycodone Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oxycodone Drugs Market

34. Recent Developments In The Oxycodone Drugs Market

35. Oxycodone Drugs Market High Potential Countries, Segments and Strategies

35.1 Oxycodone Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Oxycodone Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Oxycodone Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer